Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response

European Journal of Surgical Oncology

Volumn 36, Issue 10, 2010, Pages 987-992

  Turrini, O ^a   Ychou, M ^b   Moureau Zabotto, L ^a   Rouanet, P ^b   Giovannini, M ^a   Moutardier, V ^a   Azria, D ^b   Delpero, J R ^a   Viret, F ^a  

^a INSTITUT PAOLI CALMETTES   (France)

^b CENTRE VAL D AURELLE   (France)

Author keywords

Chemoradiation; Docetaxel; Neoadjuvant; Pancreatic cancer

Indexed keywords

DOCETAXEL; TAXOID;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BILIARY SEPSIS; BLOOD DISEASE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CARCINOMATOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DRUG FEVER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FIBROSIS; HUMAN; LAPAROTOMY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MINIMAL RESIDUAL DISEASE; MORBIDITY; MULTICENTER STUDY; NAUSEA AND VOMITING; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; SIDE EFFECT; SKIN DISEASE; WEIGHT REDUCTION; ADENOCARCINOMA; ADJUVANT THERAPY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; FOLLOW UP; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PANCREAS RESECTION; PANCREATIC NEOPLASMS; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL; TREATMENT OUTCOME; TUMOR INVASION;

ADENOCARCINOMA; ADULT; AGED; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SURVIVAL ANALYSIS; TAXOIDS; TREATMENT OUTCOME;

EID: 77957126838     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.07.003     Document Type: Article

References (29)

1. L.W. Traverso Pancreatic cancer: surgery alone is not sufficient Surg Endosc 20 Suppl. 2 2006 Apr S446 S449
2. S.P. Cleary, R. Gryfe, and M. Guindi Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors J Am Coll Surg 198 5 2004 May 722 731
3. J.P. Neoptolemos, D.D. Stoken, and H. Friess A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 12 2004 1200 1210
4. H. Oettle, S. Post, and P. Neuhaus Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial JAMA 297 3 2007 267 277
5. T.A. Aloia, J.E. Lee, and J.N. Vauthey Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy? J Am Coll Surg 204 3 2007 Mar 347 355
6. C.H. Crane, G. Varadhachary, and R.A. Wolff The argument for pre-operative chemoradiation for localized, radiographically resectable pancreatic cancer Best Pract Res Clin Gastroenterol 20 2 2006 365 382
7. J.D. Wayne, E.K. Abdalla, and R.A. Wolff Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation Oncologist 7 1 2002 34 45
8. D.B. Evans, T.A. Rich, and D.R. Byrd Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas Arch Surg 127 11 1992 Nov 1335 1339
9. F.R. Spitz, J.L. Abbruzzese, and J.E. Lee Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas J Clin Oncol 15 3 1997 Mar 928 937
10. J.P. Hoffman, S. Lipsitz, and T. Pisansky Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study J Clin Oncol 16 1 1998 Jan 317 323
11. H. Snady, H. Bruckner, and A. Cooperman Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial Cancer 89 2 2000 Jul 15 314 327
12. T.M. Breslin, K.R. Hess, and D.B. Harbison Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration Ann Surg Oncol 8 2 2001 Mar 123 132
13. R.R. White, H.I. Hurwitz, and M.A. Morse Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas Ann Surg Oncol 8 10 2001 Dec 758 765
14. V.K. Mehta, G. Fisher, and J.A. Ford Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas J Gastrointest Surg 5 1 2001 Jan-Feb 27 35
15. D.B. Evans, G.R. Varadhachary, and C.H. Crane Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head J Clin Oncol 26 21 2008 July 20 3496 3502
16. G.R. Varadhachary, R.A. Wolff, and C.H. Crane Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head J Clin Oncol 26 21 2008 Jul 20 3487 3495
17. O. Turrini, F. Viret, and L. Moureau-Zabotto Neoadjuvant 5 fluorouracil-cisplatin chemoradiation effect on survival in patients with resectable pancreatic head adenocarcinoma: a ten year single institution experience Oncology 76 6 2009 413 419
18. F. Viret, M. Ychou, and A. Gonalves Docetaxel and radiotherapy and pancreatic cancer Pancreas 27 3 2003 Oct 214 219
19. M.S. Talamonti, W. Small Jr., and M.F. Mulcahy A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma Ann Surg Oncol 13 2 2006 150 158
20. C.R. Ferrone, D.M. Finkelstein, and S.P. Thayer Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma J Clin Oncol 24 18 2006 Jun 20 2897 2902
21. S.K. Maithel, S. Maloney, and C. Winston Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma Ann Surg Oncol 15 12 2008 Dec 3512 3520
22. I. Esposito, J. Kleeff, and F. Bergmann Most pancreatic cancer resections are R1 resections Ann Surg Oncol 15 6 2008 Jun
23. J.F. Griffin, S.R. Smalley, and W. Jewell Patterns of failure after curative resection of pancreatic carcinoma Cancer 66 1990 56 61
24. M. Kayahara, T. Nagakawa, and K. Ueno An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging Cancer 72 1993 2118 2123
25. S.S. Nitecki, M.G. Sarr, and T.V. Colby Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221 1995 59 66
26. C. Sperti, C. Pasquali, and A. Piccoli Recurrence after resection for ductal adenocarcinoma of the pancreas World J Surg 21 2 1997 Feb 195 200
27. O. Turrini, F. Viret, and L. Moureau-Zabotto A modified Dworak classification applied to pancreatic adenocarcinoma: a useful prognostic factor Bull Cancer 94 10 2007 Oct 1
28. A.R. Sasson, R.W. Wetherington, and J.P. Hoffman Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: analysis of histopathology and outcome Int J Gastrointest Cancer 34 2003 121 128
29. R.R. White, H.B. Xie, and M.R. Gottfried Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer Ann Surg Oncol 12 2005 212 221